Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

31.55
Delayed Data
As of Dec 02
 +0.31 / +0.99%
Today’s Change
20.39
Today|||52-Week Range
35.06
-4.45%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues48.4M13.0M14.0M12.8M
 
 
 
 
 
Depreciation And Amortization339.0K433.0K434.0K--
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses12.5M13.1M14.6M15.9M
 
 
 
 
 
Research And Development9.0M9.1M10.8M11.5M
 
 
 
 
 
Total Operating Expenses12.9M13.6M15.1M15.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income35.6M-565.0K-1.1M-3.1M
 
 
 
 
 
Extraordinary Credit0.0075.0K0.00--
 
 
Extraordinary Charge-15.0K0.00-16.0K--
 
 
 
Interest Expense On Debt12.0K11.0K11.0K--
 
 
 
 
Other Expenses0.000.000.00471.0K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income35.9M-93.0K-642.0K-2.6M
 
 
 
 
 
Income Taxes-9.7M-1.6M-434.0K-826.0K
 
 
 
 
 
Net Income26.2M-1.6M-1.1M-1.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS18.8M18.9M19.0M19.0M
 
 
 
 
 
Shares To Calculate EPS Diluted19.3M18.9M19.0M19.0M
 
 
 
 
 
 
Earnings Per ShareEPS$1.36-$0.09-$0.06-$0.09
 
 
 
 
 
EPS Diluted$1.36-$0.09-$0.06-$0.09